Provectus Biopharmaceuticals, Inc.

PVCT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Apr 29, 2026 4
8-K Apr 21, 2026 8-K
PRE 14A Apr 20, 2026 PRE 14A
4 Apr 6, 2026 4
4 Mar 26, 2026 4
10-K Mar 26, 2026 10-K
4 Mar 20, 2026 4
4 Mar 16, 2026 4
4 Mar 6, 2026 4
4 Feb 27, 2026 4
4 Feb 23, 2026 4
4 Feb 23, 2026 4
4 Feb 17, 2026
4 Feb 11, 2026 4
4 Feb 9, 2026 4
8-K Feb 2, 2026 8-K
4 Feb 2, 2026 4
4 Jan 29, 2026 4
4 Jan 16, 2026 4
4 Dec 15, 2025
4 Dec 8, 2025 4
SCHEDULE 13D Dec 8, 2025
SCHEDULE 13D/A Dec 1, 2025
4 Nov 28, 2025
4 Nov 21, 2025 4
← Newer Page 2 of 43 · 1071 filings Older →